Cargando…

Determinants of TRPV4 Activity following Selective Activation by Small Molecule Agonist GSK1016790A

TRPV4 (Transient Receptor Potential Vanilloid 4) channels are activated by a wide range of stimuli, including hypotonic stress, non-noxious heat and mechanical stress and some small molecule agonists (e.g. phorbol ester 4α-PDD). GSK1016790A (GSK101) is a recently discovered specific small molecule a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Min, Wu, Zizhen, Chen, Ling, Jaimes, Jose, Collins, Diana, Walters, Edgar T., O'Neil, Roger G.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038856/ https://www.ncbi.nlm.nih.gov/pubmed/21339821 http://dx.doi.org/10.1371/journal.pone.0016713

Ejemplares similares

The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 Channels
por: Baratchi, Sara, et al.
Publicado: (2019)

Structural insights into TRPV2 activation by small molecules
por: Pumroy, Ruth A., et al.
Publicado: (2022)

Emerging Role of the Calcium-Activated, Small Conductance, SK3 K(+) Channel in Distal Tubule Function: Regulation by TRPV4
por: Berrout, Jonathan, et al.
Publicado: (2014)

The pain receptor TRPV1 displays agonist-dependent activation stoichiometry
por: Hazan, Adina, et al.
Publicado: (2015)

Correction: Emerging Role of the Calcium-Activated, Small Conductance, SK3 K(+) Channel in Distal Tubule Function: Regulation by TRPV4
por: Berrout, Jonathan, et al.
Publicado: (2016)

Purinergic Activation of Ca(2+)-Permeable TRPV4 Channels Is Essential for Mechano-Sensitivity in the Aldosterone-Sensitive Distal Nephron
por: Mamenko, Mykola, et al.
Publicado: (2011)

TRPV1: Structure, Endogenous Agonists, and Mechanisms
por: Benítez-Angeles, Miguel, et al.
Publicado: (2020)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
por: Tamura, Tatsuya, et al.
Publicado: (2016)

A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation
por: Marshall, Jason D., et al.
Publicado: (2016)

Promotion of natural tooth repair by small molecule GSK3 antagonists
por: Neves, Vitor C. M., et al.
Publicado: (2017)

Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists
por: Claff, Tobias, et al.
Publicado: (2019)

GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice
por: Pearce, Andrew C., et al.
Publicado: (2021)

Small Molecule Bax Agonists for Cancer Therapy
por: Xin, Meiguo, et al.
Publicado: (2014)

Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain
por: Kanju, Patrick, et al.
Publicado: (2016)

Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
por: Hong, Chuan, et al.
Publicado: (2021)

Comparative Analysis of Single-Molecule Dynamics of TRPV1 and TRPV4 Channels in Living Cells
por: Kuwashima, Yutaro, et al.
Publicado: (2021)

Modeling structure–activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics
por: Pirzada, Rameez Hassan, et al.
Publicado: (2023)

Structural determinants of TRPV4 inhibition and identification of new antagonists with antiviral activity
por: Doñate‐Macian, Pablo, et al.
Publicado: (2020)

Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
por: Miura, Shin-ichiro, et al.
Publicado: (2012)

Antithetic effects of agonists and antagonists on the structural fluctuations of TRPV1 channel
por: Sumino, Ayumi, et al.
Publicado: (2023)

Mechanism for phosphoinositide selectivity and activation of TRPV1 ion channels
por: Ufret-Vincenty, Carmen A., et al.
Publicado: (2015)

Tumor necrosis factor α sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine
por: Spicarova, Diana, et al.
Publicado: (2010)

Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models
por: Kramer, Thomas, et al.
Publicado: (2012)

Modification of TRPV4 activity by acetaminophen
por: Nakagawa, Fumio, et al.
Publicado: (2020)

Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
por: Kaftanovskaya, Elena M., et al.
Publicado: (2017)

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
por: Miura, Shin-ichiro, et al.
Publicado: (2013)

Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1
por: Zygmunt, Peter M., et al.
Publicado: (2013)

Structural determinants of 5′,6′-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel
por: Berna-Erro, Alejandro, et al.
Publicado: (2017)

Paradoxic effects of propofol on visceral pain induced by various TRPV1 agonists
por: JI, WENJIN, et al.
Publicado: (2013)

A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis
por: Xu, Suowen, et al.
Publicado: (2016)

Capsaicin, The Vanilloid Receptor TRPV1 Agonist in Neuroprotection: Mechanisms Involved and Significance
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2023)

Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical and thermal allodynia after burn injury
por: Green, Dustin P, et al.
Publicado: (2016)

Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site
por: Rippin, Ido, et al.
Publicado: (2020)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
por: Anderson, Ross C., et al.
Publicado: (2019)

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2019)

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development
por: Steeghs, Neeltje, et al.
Publicado: (2022)

Mechanism for Regulation of Melanoma Cell Death via Activation of Thermo-TRPV4 and TRPV2
por: Zheng, Jiaojiao, et al.
Publicado: (2019)

Expression of a Diverse Array of Ca(2+)-Activated K(+) Channels (SK1/3, IK1, BK) that Functionally Couple to the Mechanosensitive TRPV4 Channel in the Collecting Duct System of Kidney
por: Li, Yue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i4ho045it4fj1q2cqq3rhqncrm